Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Roche, Sygnis, Argonaut, and More

NEW YORK (GenomeWeb) – Roche announced this week that it has launched a Certified Service Provider program for its SeqCap EZ Target Enrichment Systems utilizing Kapa library preparation kits. The program involves training and certification of genomic service providers to ensure consistent and robust results from the SeqCap EZ Target Enrichment products. The first genomics service providers to be certified under the new program are Centro Nacional de Análisis Genómico in Spain and China’s Genergy Biotechnology.

Sygnis said this week that it has completed the integration of life sciences tools firm CBS Scientific, which Sygnis acquired in December 2016. As part of the integration, Sygnis consolidated the former sites of Expedeon and CBS, which are both located in San Diego. As of March 31, all teams had been integrated and are now fully operational, the firm said. CBS products will now also be sold through Sygnis’ sales force.

Argonaut Manufacturing Services announced this week that it has registered with the US Food and Drug Administration as a medical device establishment. The registration follows an earlier ISO 13485:2016 certification.

Bioké said this week that it has signed an agreement to become the exclusive distributor of Bethyl Laboratories’ products in Belgium, the Netherlands, and Luxembourg. Bethyl’s portfolio currently consists of more than 7,150 catalog products, including about 5,700 primary antibodies targeting over 2,700 proteins, and 1,450 secondary antibodies raised against immunoglobulins from more than 25 species.

CloudLIMS this week received ISO 9001:2015 certification, ensuring it meets certain requirements to be considered a Quality Management System.

KeyGene and Malaysia’s Felda Global Ventures announced this week that they have signed a memorandum of collaboration to start a joint research laboratory. This joint lab will enable FGV to strengthen its research capabilities, which will lead to faster introduction of better and more sustainable oil palm varieties to the market, the companies said.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.